Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 10,980 shares at $13.26 ($146K) on 2017-11-10, disclosed to the SEC on 2017-11-13.
Open-market sale of $146k VYGR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.26 | 5,490 | $73K | 50.0% |
| 2 | $13.26 | 5,490 | $73K | 50.0% |
| Total | $13.26 avg | 10,980 | $146K | 100% |
| Filing → |
| VYGR | SELL | 2018-02-13 | $45K | — | Filing → |
| VYGR | SELL | 2018-01-12 | $119K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |